Revista CPAQV - Centro de Pesquisas Avançadas Em Qualidade de Vida · Nov 3, 2026

Preservation of muscle mass during pharmacological treatment of obesity: evidence on nutritional strategies and physical exercise in users of GLP-1 agonists and dual GIP/GLP-1 agonists — a systematic review

By Bomfim BO, Reis IGSS, Moura FDS et al.

INTRODUCTION: Pharmacological treatment of obesity with glucagon-like peptide-1 (GLP-1) receptor agonists and dual GIP/GLP-1 receptor agonists promotes substantial body weight reduction but may be accompanied by a decrease in lean mass, making the investigation of strategies to preserve musculoskeletal health relevant. OBJECTIVE: To analyze the scientific evidence on the efficacy of nutritional strategies and physical exercise in preserving muscle mass, strength, and physical function in adults with overweight or obesity treated with these medications. METHODS: A systematic literature review was proposed, guided by the PRISMA 2020 recommendations, focusing on studies of nutritional interventions, protein intake, supplementation, and physical exercise. Aspects related to body composition, muscle strength, physical function, and the methodological quality of the evidence were considered. RESULTS: The publications examined indicated that treatment with semaglutide and tirzepatide may promote reductions in both fat mass and lean mass. Nutritional adequacy and resistance training were identified as relevant strategies for musculoskeletal care during weight loss. However, the directly available evidence on the efficacy of specific interventions to preserve muscle in users of these medications still has limitations. CONCLUSIONS: The integration of pharmacological treatment, individualized nutritional monitoring, and physical exercise constitutes a promising approach to enhance the benefits of obesity treatment. Additional clinical studies are needed to directly assess the effects of these interventions on muscle mass, strength, and physical function.

doi.org/10.36692/v18n2-39rOpen accessInterventions

AgingResearch.News